window.protocolData = window.protocolData || {};
window.protocolData.renal = {
  "adjuvant": {
    "Pembrolizumab": {
      "name": "Pembrolizumab (KEYNOTE-564) (PD-1 inhibitor)",
      "cycles": 17,
      "drugs": [
        {
          "name": "Pembrolizumab",
          "dose": 200,
          "unit": "mg",
          "schedule": "D1, every 21 days x 17 cycles (1 year) (or 400mg q6weeks x 9 cycles)"
        }
      ]
    }
  },
  "metastatic": {
    "Lenvatinib-Pembrolizumab": {
      "name": "Lenvatinib + Pembrolizumab (CLEAR) (NCCN Preferred)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Lenvatinib",
          "dose": 20,
          "unit": "mg",
          "schedule": "PO daily, continuously"
        },
        {
          "name": "Pembrolizumab",
          "dose": 200,
          "unit": "mg",
          "schedule": "D1, every 21 days (or 400mg q6weeks)"
        }
      ]
    },
    "Nivolumab-Ipilimumab": {
      "name": "Nivolumab + Ipilimumab (CheckMate-214) (NCCN Preferred)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Nivolumab",
          "dose": 3,
          "unit": "mg/kg",
          "schedule": "D1, every 21 days x 4 cycles, then 240mg every 14 days or 480mg every 28 days"
        },
        {
          "name": "Ipilimumab",
          "dose": 1,
          "unit": "mg/kg",
          "schedule": "D1, every 21 days x 4 cycles only"
        }
      ]
    },
    "Nivolumab-Cabozantinib": {
      "name": "Nivolumab + Cabozantinib (CheckMate-9ER) (NCCN Preferred)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Nivolumab",
          "dose": 240,
          "unit": "mg",
          "schedule": "D1, every 14 days (or 480mg every 28 days)"
        },
        {
          "name": "Cabozantinib",
          "dose": 40,
          "unit": "mg",
          "schedule": "PO daily, continuously"
        }
      ]
    },
    "Pembrolizumab-Axitinib": {
      "name": "Pembrolizumab + Axitinib (KEYNOTE-426) (NCCN Preferred)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Pembrolizumab",
          "dose": 200,
          "unit": "mg",
          "schedule": "D1, every 21 days (or 400mg q6weeks)"
        },
        {
          "name": "Axitinib",
          "dose": 5,
          "unit": "mg",
          "schedule": "PO twice daily, continuously"
        }
      ]
    },
    "Avelumab-Axitinib": {
      "name": "Avelumab + Axitinib (JAVELIN Renal 101)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Avelumab",
          "dose": 800,
          "unit": "mg",
          "schedule": "D1, every 14 days"
        },
        {
          "name": "Axitinib",
          "dose": 5,
          "unit": "mg",
          "schedule": "PO twice daily, continuously"
        }
      ]
    },
    "Cabozantinib": {
      "name": "Cabozantinib (CABOSUN/METEOR)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Cabozantinib",
          "dose": 60,
          "unit": "mg",
          "schedule": "PO daily, continuously"
        }
      ]
    },
    "Sunitinib": {
      "name": "Sunitinib",
      "cycles": 12,
      "drugs": [
        {
          "name": "Sunitinib",
          "dose": 50,
          "unit": "mg",
          "schedule": "PO daily, 4 weeks on / 2 weeks off (6-week cycle) (or 37.5mg continuous daily)"
        }
      ]
    },
    "Pazopanib": {
      "name": "Pazopanib",
      "cycles": 12,
      "drugs": [
        {
          "name": "Pazopanib",
          "dose": 800,
          "unit": "mg",
          "schedule": "PO daily on empty stomach, continuously"
        }
      ]
    },
    "Axitinib": {
      "name": "Axitinib (AXIS) (2L+)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Axitinib",
          "dose": 5,
          "unit": "mg",
          "schedule": "PO twice daily, continuously (titrate up to 10mg BID if tolerated)"
        }
      ]
    },
    "Sorafenib": {
      "name": "Sorafenib (TARGET)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Sorafenib",
          "dose": 400,
          "unit": "mg",
          "schedule": "PO twice daily, continuously"
        }
      ]
    },
    "Tivozanib": {
      "name": "Tivozanib (TIVO-3) (3L+)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Tivozanib",
          "dose": 1.34,
          "unit": "mg",
          "schedule": "PO daily, 21 days on / 7 days off (28-day cycle)"
        }
      ]
    },
    "Nivolumab": {
      "name": "Nivolumab (CheckMate-025) (2L+ after prior TKI)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Nivolumab",
          "dose": 240,
          "unit": "mg",
          "schedule": "D1, every 14 days (or 480mg every 28 days)"
        }
      ]
    },
    "Lenvatinib-Everolimus": {
      "name": "Lenvatinib + Everolimus (Study 205) (2L+)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Lenvatinib",
          "dose": 18,
          "unit": "mg",
          "schedule": "PO daily, continuously"
        },
        {
          "name": "Everolimus",
          "dose": 5,
          "unit": "mg",
          "schedule": "PO daily, continuously"
        }
      ]
    },
    "Everolimus": {
      "name": "Everolimus (RECORD-1) (2L+)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Everolimus",
          "dose": 10,
          "unit": "mg",
          "schedule": "PO daily, continuously"
        }
      ]
    },
    "Belzutifan": {
      "name": "Belzutifan (LITESPARK-005) (HIF-2α inhibitor) (post PD-1/PD-L1 + post VEGF-TKI)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Belzutifan",
          "dose": 120,
          "unit": "mg",
          "schedule": "PO daily, continuously"
        }
      ]
    },
    "Belzutifan-VHL": {
      "name": "Belzutifan (HIF-2α inhibitor) (VHL disease-associated RCC)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Belzutifan",
          "dose": 120,
          "unit": "mg",
          "schedule": "PO daily, continuously"
        }
      ]
    },
    "Erlotinib-Bevacizumab": {
      "name": "Erlotinib + Bevacizumab (HLRCC-associated RCC)",
      "cycles": 12,
      "drugs": [
        {
          "name": "Erlotinib",
          "dose": 150,
          "unit": "mg",
          "schedule": "PO daily, continuously"
        },
        {
          "name": "Bevacizumab",
          "dose": 10,
          "unit": "mg/kg",
          "schedule": "D1, every 14 days"
        }
      ]
    },
    "Pembrolizumab": {
      "name": "Pembrolizumab (MSI-H/dMMR/TMB-H)",
      "cycles": 35,
      "drugs": [
        {
          "name": "Pembrolizumab",
          "dose": 200,
          "unit": "mg",
          "schedule": "D1, every 21 days (or 400mg q6weeks)"
        }
      ]
    }
  }
};
